Chennai Pharma Industrial Infrastructure Upgradtaion Company Profile
Key Indicators
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -44.59%
(FY 2021)
- Profit 11.72%
(FY 2021)
- Ebitda 14.55%
(FY 2021)
- Net Worth -38.90%
(FY 2021)
- Total Assets 10.42%
(FY 2021)
About Chennai Pharma Industrial Infrastructure Upgradtaion Company
The Company is engaged in the Infrastructure And Utilities Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Nagarajan Mookkappan, Ganesan Natarajan, and Rajesh Jain serve as directors at the Company.
- CIN/LLPIN
U91990TN2004NPL053852
- Company No.
053852
- Company Classification
Public Not For Profit Company
- Incorporation Date
30 Jul 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Chennai Pharma Industrial Infrastructure Upgradtaion Company?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagarajan Mookkappan  | Director | 26-Sep-2018 | Current |
| Ganesan Natarajan | Director | 18-Mar-2024 | Current |
| Rajesh Jain | Director | 28-Mar-2019 | Current |
Financial Performance of Chennai Pharma Industrial Infrastructure Upgradtaion Company.
Chennai Pharma Industrial Infrastructure Upgradtaion Company, for the financial year ended 2021, experienced significant reduction in revenue, with a 44.59% decrease. The company also saw a substantial improvement in profitability, with a 11.72% increase in profit. The company's net worth observed a substantial decline by a decrease of 38.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chennai Pharma Industrial Infrastructure Upgradtaion Company?
Unlock access to Chennai Pharma Industrial Infrastructure Upgradtaion Company's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chennai Pharma Industrial Infrastructure Upgradtaion Company?
Unlock and access historical data on people associated with Chennai Pharma Industrial Infrastructure Upgradtaion Company, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chennai Pharma Industrial Infrastructure Upgradtaion Company, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chennai Pharma Industrial Infrastructure Upgradtaion Company's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
